Evidence map›Paper›PMID 41301576›Full record

ReviewAntibiotics (Basel, Switzerland)2025

A Century of Bacteriophages: Insights, Applications, and Current Utilization.

Sadika Dkhili, Miguel Ribeiro, Karim Ben Slama

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sadika DkhiliLaboratoire de Recherche "Bioressources, Environnement et Biotechnologie (BeB)" LR22ES04, Institut Supérieur des Sciences Biologiques Appliquées de Tunis, Université de Tunis El Manar, Avenue Docteur Zouheir Essefi, Tunis 1006, Tunisia.
Miguel RibeiroDepartment of Genetics and Biotechnology (DGB), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal.ORCID 0000-0002-6497-8337
Karim Ben SlamaLaboratoire de Recherche "Bioressources, Environnement et Biotechnologie (BeB)" LR22ES04, Institut Supérieur des Sciences Biologiques Appliquées de Tunis, Université de Tunis El Manar, Avenue Docteur Zouheir Essefi, Tunis 1006, Tunisia.ORCID 0000-0001-5745-3930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages or phages are viruses that exclusively target and replicate within bacteria, acting as natural predators in the biosphere. Since their discovery over a century ago, host-specific bacteriophages have been widely advocated as a cost-effective and adaptable approach to controlling and combating bacterial infections. Antibiotic resistance, a growing concern and a significant global public health problem, has further underscored the importance of bacteriophages. Nevertheless, their potential applications span diverse fields, including molecular biology, phage therapy, bacterial detection, food safety, and wastewater decontamination. Furthermore, bacteriophages represent a diverse group of viruses that are relatively easy to handle, making them suitable for use in both treatments and biotechnology research. In this review, we aim to provide a comprehensive overview of bacteriophage history, characteristics, and applications that have been employed to address human challenges, ranging from healthcare to environmental remediation. We will highlight key findings and outcomes, shedding light on ongoing research that will shape the future of bacteriophage applications.

Indexed as

antimicrobial resistancebacteriophagesenvironmental remediationfood safetyhealth therapywater treatment

Identifiers

PMID41301576
PMCPMC12649462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.